1 – 22 of 22
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Preoperative beta blockers and other drugs in relation to anastomotic leakage after anterior resection for rectal cancer
2024) In Colorectal Disease(
- Contribution to journal › Article
- 2023
-
Mark
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
(
- Contribution to journal › Article
-
Mark
Association of metformin use and survival in patients with cutaneous melanoma and diabetes
(
- Contribution to journal › Article
- 2022
-
Mark
Metformin enhances LDL-cholesterol uptake by suppressing the expression of the pro-protein convertase subtilisin/kexin type 9 (PCSK9) in liver cells
(
- Contribution to journal › Article
- 2020
-
Mark
Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation
(
- Contribution to journal › Article
- 2019
-
Mark
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes : A nested, case–control study
(
- Contribution to journal › Article
-
Mark
Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes
(
- Contribution to journal › Article
- 2018
-
Mark
Mitochondrial medicine. New strategies to evaluate drug toxicity and develop pharmacological protection of the cell’s powerhouse.
2018)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Bioenergetic bypass using cell-permeable succinate, but not methylene blue, attenuates metformin-induced lactate production
(
- Contribution to journal › Article
-
Mark
Divergent effects of metformin on an inflammatory model of Parkinson’s disease
(
- Contribution to journal › Article
- 2017
-
Mark
Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver
(
- Contribution to journal › Article
-
Mark
Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes
(
- Contribution to journal › Article
-
Mark
The Liver Circadian Clock Modulates Biochemical and Physiological Responses to Metformin
(
- Contribution to journal › Article
-
Mark
Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes : Results from a randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes
(
- Contribution to journal › Article
- 2015
-
Mark
Worse breast cancer prognosis in insulin treated diabetic patients - A population based registry study in Sweden
(
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
The impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Renal function in a large cohort of metformin treated patients with type 2 diabetes mellitus
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes
(
- Contribution to journal › Article
- 2007
-
Mark
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial
(
- Contribution to journal › Article
- 2006
-
Mark
Glycemic and non-glycemic effects of pioglitazone in triple oral therapy in patients with type 2 diabetes mellitus
(
- Contribution to journal › Article
- 2000
-
Mark
Pharmacoepidemiologic Studies of Diabetes Mellitus - with special reference to - Glucose Control and Prognosis of Type 2 Diabetes
2000)(
- Thesis › Doctoral thesis (compilation)